Global Human Placental Protein Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Human Placental Protein Market Insights, Forecast to 2034
A placenta is an organ that connects the developing fetus to the uterine wall to allow nutrient uptake, thermo-regulation, waste elimination, and gas exchange through the mothers blood supply. In addition, it aids in fighting against internal infection and produces hormones to support pregnancy. This placenta is further hydrolyzed and is used for a variety of applications as it has lactogenic, luteotropic, and growth-promoting action, and prevents maternal insulin action during pregnancy.
Market Analysis and InsightsGlobal Human Placental Protein Market
Global Human Placental Protein market is expected to reach to US$ 987.6 million in 2023, with a positive growth of %, compared with US$ 889.1 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Human Placental Protein industry is evaluated to reach US$ 1747.6 million in 2033. The CAGR will be 10.0% during 2023 to 2033.
Skin Care Products are expected to dominate the global human placental protein market in the forecast period. This can be attributed to the rising prevalence of cosmetics products among the targeted population and the increasing number of menopause population. As the placenta connects developing fetus to the uterine wall to all nutrients uptake, thermoregulation, fighting against internal infection and produce hormones to support pregnancy, which makes placenta protein highly nutritious and thus it further hydrolyzed and use it for many skincare products and hair care treatments. In addition, with the increasing aging population worldwide, the human placental protein extract has been extensively used for anti-aging therapy and is promoting the growth of the overall market.
Report Covers
This report presents an overview of global Human Placental Protein market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Human Placental Protein market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Japan Bio Products GmbH
R&D Systems, Inc
Abcam Plc
Clontech Laboratories, Inc
Lee Biosolutions, Inc
Kamiya Biomedical Company
Scripps Laboratories
VWR International
Elabscience Biotechnology Co.,Ltd
Hunan World Well-Being Bio-Tech Co., Ltd
Takara Bio Inc
MED Skincare
CJT
Charites Japan
Bioon
Japan Natural Laboratories
Height Long Jiang Yinhe
Albert David Ltd.
MF3 LTD
SR GROUP
SGSTEMCELL
NOVA Biologics, Inc
Creative Enzymes
Melsmon Pharmaceutical Co., Ltd
Bovogen Biologicals Pty Ltd
Segment by Type
Hydrolyzed Human Placental Protein
Human Placental Enzymes
Others
Life Science
Tumor Markers
Testing/Assay Validation
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Human Placental Protein introduction, etc. Human Placental Protein Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Human Placental Protein
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Human Placental Protein Market
Global Human Placental Protein market is expected to reach to US$ 987.6 million in 2023, with a positive growth of %, compared with US$ 889.1 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Human Placental Protein industry is evaluated to reach US$ 1747.6 million in 2033. The CAGR will be 10.0% during 2023 to 2033.
Skin Care Products are expected to dominate the global human placental protein market in the forecast period. This can be attributed to the rising prevalence of cosmetics products among the targeted population and the increasing number of menopause population. As the placenta connects developing fetus to the uterine wall to all nutrients uptake, thermoregulation, fighting against internal infection and produce hormones to support pregnancy, which makes placenta protein highly nutritious and thus it further hydrolyzed and use it for many skincare products and hair care treatments. In addition, with the increasing aging population worldwide, the human placental protein extract has been extensively used for anti-aging therapy and is promoting the growth of the overall market.
Report Covers
This report presents an overview of global Human Placental Protein market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Human Placental Protein market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Japan Bio Products GmbH
R&D Systems, Inc
Abcam Plc
Clontech Laboratories, Inc
Lee Biosolutions, Inc
Kamiya Biomedical Company
Scripps Laboratories
VWR International
Elabscience Biotechnology Co.,Ltd
Hunan World Well-Being Bio-Tech Co., Ltd
Takara Bio Inc
MED Skincare
CJT
Charites Japan
Bioon
Japan Natural Laboratories
Height Long Jiang Yinhe
Albert David Ltd.
MF3 LTD
SR GROUP
SGSTEMCELL
NOVA Biologics, Inc
Creative Enzymes
Melsmon Pharmaceutical Co., Ltd
Bovogen Biologicals Pty Ltd
Segment by Type
Hydrolyzed Human Placental Protein
Human Placental Enzymes
Others
Segment by Application
Life Science
Tumor Markers
Testing/Assay Validation
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Human Placental Protein introduction, etc. Human Placental Protein Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Human Placental Protein
Chapter 13Methodology and Data Sources adopted by MRAResearch